This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (18)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Reversing a Decade of Underutilization of Hepatitis B Vaccine

Donald P. Francis, MD, DSc

JAMA. 1995;274(15):1242-1243.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A series of studies published between 1980 and 1985 reported that hepatitis B vaccine effectively prevented hepatitis B virus (HBV) infection of adults,^1,2 children,³ and infants.⁴ Recognizing that these discoveries set the stage for control of HBV infection and its associated disease, I, from my position at the Centers for Disease Control and Prevention (CDC), published an editorial in 1985 suggesting worldwide application of this vaccine to eliminate both the acute and chronic diseases associated with HBV infection.⁵ But progress toward this end was slow, and 4 years later, in another attempt to stimulate international attention, Harold Margolis, MD, (then and now Chief of the Hepatitis Branch at CDC) and I wrote another plaintive Editorial in JAMA.⁶

See also pp 1201 and 1209.

With reports of long-term vaccine protection,^7,8 interest in broader application of hepatitis B vaccine was rekindled, and in late 1991 routine . . . [Full Text PDF of this Article]

Footnotes
From Genentech Inc, South San Francisco, Calif.

The opinions expressed herein are those of the author and do not necessarily reflect those of Genentech Inc.

Reprint requests to Genentech Inc, 460 Point San Bruno Blvd, South San Francisco, CA 94080 (Dr Francis).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?